Lombard Odier Asset Management Europe Ltd Invests $9.53 Million in Chemed Co. (NYSE:CHE)

Lombard Odier Asset Management Europe Ltd bought a new position in Chemed Co. (NYSE:CHE - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 17,572 shares of the company's stock, valued at approximately $9,534,000. Lombard Odier Asset Management Europe Ltd owned 0.12% of Chemed at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CHE. Rise Advisors LLC purchased a new position in shares of Chemed in the 1st quarter worth about $26,000. GAMMA Investing LLC lifted its position in Chemed by 34.4% during the second quarter. GAMMA Investing LLC now owns 86 shares of the company's stock valued at $47,000 after buying an additional 22 shares in the last quarter. Mather Group LLC. acquired a new position in Chemed during the first quarter valued at approximately $67,000. EntryPoint Capital LLC increased its position in shares of Chemed by 14.0% in the first quarter. EntryPoint Capital LLC now owns 147 shares of the company's stock worth $94,000 after acquiring an additional 18 shares in the last quarter. Finally, Janiczek Wealth Management LLC raised its stake in shares of Chemed by 154.5% in the 1st quarter. Janiczek Wealth Management LLC now owns 196 shares of the company's stock valued at $126,000 after acquiring an additional 119 shares during the period. Institutional investors and hedge funds own 95.85% of the company's stock.

Insider Buying and Selling

In other Chemed news, EVP Nicholas Michael Westfall sold 1,713 shares of Chemed stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $569.35, for a total transaction of $975,296.55. Following the sale, the executive vice president now directly owns 6,109 shares in the company, valued at approximately $3,478,159.15. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction that occurred on Monday, August 5th. The stock was sold at an average price of $569.63, for a total value of $1,139,260.00. Following the completion of the sale, the chief executive officer now directly owns 105,735 shares in the company, valued at approximately $60,229,828.05. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Nicholas Michael Westfall sold 1,713 shares of the firm's stock in a transaction on Monday, September 9th. The shares were sold at an average price of $569.35, for a total value of $975,296.55. Following the completion of the sale, the executive vice president now owns 6,109 shares in the company, valued at $3,478,159.15. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 6,744 shares of company stock worth $3,828,231. 3.32% of the stock is currently owned by corporate insiders.

Chemed Stock Performance

Chemed stock traded up $7.22 during trading on Monday, reaching $589.28. 54,382 shares of the company's stock were exchanged, compared to its average volume of 84,363. Chemed Co. has a 52-week low of $497.36 and a 52-week high of $654.62. The firm has a market cap of $8.92 billion, a price-to-earnings ratio of 31.33, a PEG ratio of 2.31 and a beta of 0.44. The company's 50-day moving average is $569.34 and its two-hundred day moving average is $577.23.

Chemed (NYSE:CHE - Get Free Report) last posted its earnings results on Wednesday, July 24th. The company reported $5.47 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.59 by ($0.12). The company had revenue of $595.88 million during the quarter, compared to analyst estimates of $599.20 million. Chemed had a net margin of 12.88% and a return on equity of 29.21%. Chemed's quarterly revenue was up 7.6% compared to the same quarter last year. During the same quarter last year, the business posted $4.71 EPS. Analysts anticipate that Chemed Co. will post 21.77 EPS for the current year.

Chemed Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Monday, August 12th were paid a dividend of $0.50 per share. The ex-dividend date was Monday, August 12th. This is an increase from Chemed's previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a dividend yield of 0.34%. Chemed's dividend payout ratio (DPR) is currently 10.76%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.